Clinical Trial Update: Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ceftazidime-avibactam plus metronidazole to meropenem in hospitalized adults with complicated intra-abdominal infections completed; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection

Drugs mentioned

• Meropenem (Meropenem)
• ceftazidime-avibactam + metronidazole

Snippet

Sponsor: Pfizer | Conditions: Complicated Intra-Abdominal Infection | Phase 3 | Status: COMPLETED | Results posted: 2016-03-01